← Leaderboards
David A Frank
Dana-Farber Cancer Institute
$3,215,820
Attributed
$3,215,820
Total exposure
4
Grants
2
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants. They are the sole PI on all grants (the two match).
Funding over time
peak $363.1K · FY2006–16$500K$375K$250K$125K$0
'06
'07
'08
'09
'10
'11
'12
'13
'14
'15
'16
Funding mix
By agency
NIH$3,215,820 · 4
By mechanism
R01$2,825,473 · 2
R21$304,847 · 1
R03$85,500 · 1
Top collaborators
No co-investigators on record.
Most similar at Dana-Farber Cancer Institute
Same institution · by research overlap
- Jiandie D Lin$18,339,588
- Peter M Mauch$3,288,613
- D Gary Gilliland$5,135,266
- Richard D Kolodner$25,032,745
- Kimberly Stegmaier$26,925,503
Others in their field
Top investigators on “Transcription Factor”
- Michael P Snyder · Yale University$110,571,583
- Richard M Myers · Hudson-Alpha Institute For Biotechnology$57,320,347
- Eric J Nestler · Icahn School Of Medicine At Mount Sinai$55,523,574
- Angela M. Gronenborn · Diabetes, Digestive, Kidney Diseases$45,640,184
- Richard K. Wilson · Washington University$45,224,621
- Deborah Nickerson · University Of Washington$35,131,320
Research focus
Transcription FactorGene ExpressionProteinsMolecular TargetCellsStat3 GeneGenesCytotoxicMalignant - DescriptorMolecularAnimal ModelPlayResearch StudyBiological Signal TransductionBiologyInhibitor/AntagonistBaseGene Induction /RepressionCancer CellBehaviorCancer TherapyMalignant NeoplasmsPhenotypeTumor
Grant awards (12)
Dual STAT3/NF-kB Inhibitors for Targeted Cancer Therapy$363,125
R01 · FY2016 · CA · contact PI
Dual STAT3/NF-kB Inhibitors for Targeted Cancer Therapy$363,125
R01 · FY2015 · CA · contact PI
Dual STAT3/NF-kB Inhibitors for Targeted Cancer Therapy$352,231
R01 · FY2014 · CA · contact PI
Dual STAT3/NF-kB Inhibitors for Targeted Cancer Therapy$341,338
R01 · FY2013 · CA · contact PI
Dual STAT3/NF-kB Inhibitors for Targeted Cancer Therapy$363,125
R01 · FY2012 · CA · contact PI
STAT3 in the Pathogenesis and Treatment of Pancreatic Cancer$175,140
R21 · FY2007 · CA · contact PI
STAT3 in the Pathogenesis and Treatment of Pancreatic Cancer$129,707
R21 · FY2006 · CA · contact PI
High Throughput Screening for Modulators of STAT5 (RMI)$85,500
R03 · FY2004 · NS
STAT SIGNALING IN CHRONIC LYMPHOCYTIC LEUKEMIA$272,299
R01 · FY2003 · CA
STAT SIGNALING IN CHRONIC LYMPHOCYTIC LEUKEMIA$264,370
R01 · FY2002 · CA
STAT SIGNALING IN CHRONIC LYMPHOCYTIC LEUKEMIA$256,667
R01 · FY2001 · CA
STAT SIGNALING IN CHRONIC LYMPHOCYTIC LEUKEMIA$249,193
R01 · FY2000 · CA